[Clinical outcome of beta blocker therapy in a patient with long QT syndrome with a critical mutation in the pore of potassium channel].
Barragán Acea
Antonio
A
Perera Carrillo
César
C
Rayo Gutiérrez
Manuel
M
Marrero Rodríguez
Francisco
F
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002648:Child; D004562:Electrocardiography; D006801:Humans; D008133:Long QT Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D017354:Point Mutation / Q000235:genetics; D015221:Potassium Channels / Q000187:drug effects / Q000235:genetics; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D015221:Potassium Channels